On the other hand, and to our surprise, fructosamine concentrations in the survey specimens were higher in the ABA-VP (3/') than in the Multistat (x') and least-squares regression of those data (n = 24) gave the equation: y' = 0.992x' + 0.389 (r = 0.920, ' the liver specimen confirmed the antenatal diagnosis. Previous reports (2, 3) stated that OCT activity was not detectable before 17 weeks after the last menstrual penod, and that liver biopsy for prenatal diagnosis should not be attempted before 18 weeks of gestation. We have since expanded our data and would like to correct that statement. Fresh human fetal livers were obtained between eight and 24 weeks after the last menstrual period from patients who were undergoing dilatation and evacuation. Fetal age was determined by the last menstrual period and by fetal foot length, which was measured and compared with standard tabulated values. (counts/mm) X 2.5 X 10-6 (V)(C)(T) where 2.5 x 10_6 is a factor that combines all of the constant parameters in the formula (i.e., conversion of counts/mm to dismntegrations/min, to pCi, to prnol) to yield the total amount (mol) of citrulline that was produced; V is the volume (pL) of liver homogenate; C is the protein concentration (g/L); and T is the time in hours.
The results (Table 1) indicate that OCT activity can be detected by eight Therefore, we conclude that the prenatal diagnosis of OCT deficiency can be made by liver biopsy as early in gestation as fetal liver biopsy can be safely performed.
Identifying CK-MB and Macro-CK by Electrophoresis
To the Editor:
We have previously described a case of macro creatine kinase (CK) type 1 in which the electrophoretic mobility of the macro CK was identical to that of the MB isoenzyme ofCK (1). Evidently macro CK may be an interference in the identification of CK isoenzymes by electrophoresis. We have since seen two additional cases of such macro CKs. In all three of these cases the amount of CK-MM was less than the amount of macro CK type 1. Furthermore, in all three cases the CK isoenzyme pattern remained stable over time. These observations form the basis of two criteria that may be used to raise suspicion that a band in the MB region might be a macro CK.
CK enters the bloodstream by leaking from damaged cells (2). All cells that contain CK-MB have even more CK-MM; myocardium is richest in MB of all tissue, with CK-MB constituting 20% to 40% of the total CK activity (2, 3). Therefore, as Galen observed (2) , serum CK-MB should never exceed 40% of the total CK. This leads to the first criterion for suspecting that a band is not MB: activity greater than 40% of the total CK. Clearly, allowances must be made if CK-BB or another macro CK is present.
The most important diagnostic use of CK isoenzyme analysis is in acute myocardial infarction.
Recently, more emphasis has been placed on the ternporal pattern of CK; an appropriate increase and decline suggests an acute myocardial infarction, even if the total CK activity remains within the reference range (4). Conversely, a stable CK isoenzyrne pattern is not consistent with an acute event. Hence, the second criterion for suspecting that a band is not MB is a CK isoenzyme pattern that is unchanged over several days, regardless of the total CK. It is most important to correctly identify CK-MB vs macro CK in the setting of a patient with coronary artery disease, because a persistent CK-MB band might be interpreted as evidence of ongoing ischemia, leading to increasingly invasive therapies.
If a suspicion of macro CK type 1 is raised, it can easily be confirmed by incubating the patient's serum with anti-immunoglobulin antibodies (1).
